There are 2949 resources available
927P - Initial results from a phase II study (TACTI-002) of eftilagimod alpha (soluble LAG-3 protein) and pembrolizumab as 2<sup>nd</sup> line treatment for PD-L1 unselected metastatic head and neck cancer patients
Presenter: Martin Forster
Session: E-Poster Display
Resources:
Abstract
928P - Phase I dose-expansion (part II) study of ISU104 (a novel anti-ErbB3 monoclonal antibody) alone and combination with cetuximab (CET), in patients (pts) with recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC)
Presenter: Sung-Bae Kim
Session: E-Poster Display
Resources:
Abstract
929P - Anlotinib in patients with recurrent or metastatic nasopharyngeal carcinoma: An interim analysis of a phase II clinical trial
Presenter: Qingqing Cai
Session: E-Poster Display
Resources:
Abstract
930P - Weekly paclitaxel, carboplatin and cetuximab (PCC) as first-line treatment of recurrent and/or metastatic head & neck squamous cell carcinoma (R/M-HNSCC) for patients ineligible to cisplatin based chemotherapy
Presenter: Helene Carinato
Session: E-Poster Display
Resources:
Abstract
931P - Topical steroid versus placebo for the prevention of radiation dermatitis in head and neck cancer patients receiving chemoradiotherapy: A phase III, randomized, double-blinded trial: J-SUPPORT 1602(TOPICS)
Presenter: Tomoya Yokota
Session: E-Poster Display
Resources:
Abstract
932P - Impact of geriatric assessment on the management of older head and neck cancer patients
Presenter: Maria Plana
Session: E-Poster Display
Resources:
Abstract
933P - The impact of patients’ and physicians’ characteristics on surgery decision for head and neck cancer: Results of a national survey
Presenter: Fanny Cros
Session: E-Poster Display
Resources:
Abstract
934P - Comparing frailty screening tools for older head and neck cancer patients
Presenter: Maite Antonio
Session: E-Poster Display
Resources:
Abstract
935P - Diclofenac versus tramadol for mucositis-related pain in head and neck cancer patients undergoing concurrent chemoradiation: A phase III study
Presenter: Vikas Talreja
Session: E-Poster Display
Resources:
Abstract
936P - Outcome and toxicity in older patients with locoregionally-advanced head and neck cancer: Relevance of an oncogeriatric approach
Presenter: Sandra Llop
Session: E-Poster Display
Resources:
Abstract